Skip to content

BMRN history

Every recorded change to BMRN's data, most recent first.

  1. CurrentNext earnings date moved to Feb 2, 2027; next earnings date is now an estimate; the company overview was rewritten; the investment thesis was rewritten; the listed risks were updated; the balance sheet was rewritten; checkpoint failed: Q3 2026 earnings and hypochondroplasia update; new checkpoint: Q4 2026 results and 2027 guidance; new checkpoint: FDA decision on VOXZOGO in hypochondroplasia; recent events were updated.
  2. Next earnings date moved to Nov 2, 2026; next earnings date is now confirmed; the investment thesis was rewritten; checkpoint moved to Nov 2, 2026: Q3 2026 earnings and hypochondroplasia update.
  3. Next earnings date moved to Nov 6, 2026; the investment thesis was rewritten; checkpoint moved to Nov 6, 2026: Q3 2026 earnings and hypochondroplasia update.
  4. This company was added.